Cost containment analysis of childhood vaccination against varicella in Israel
- 29 February 2004
- journal article
- Published by Elsevier BV in Journal of Infection
- Vol. 48 (2), 119-133
- https://doi.org/10.1016/s0163-4453(03)00079-3
Abstract
Objectives. The low cost of safe and effective vaccines prompted a cost-containment evaluation of a nationwide vaccination campaign against varicella. Methods. A model incorporating demographic, epidemiologic and economic data from Israeli sources (supplemented by data from International literature) was constructed to estimate the decrease in morbidity and the consequent reductions in treatment costs and time-off work of a nationwide programme vaccinating children at 12 months. Results. A policy of aiming to immunize a cohort of all 1-year-olds in Israel in the year 2002, for an annual cost of $1.10 million to the health services and $1.27 million to society (including lost work and transport costs), would reduce the number of cases of varicella during the lifetime of a cohort from 123,984 to 10,170 cases. This morbidity reduction would reduce national expenditures by $1.80 million in health service resources alone and by $24.5 million to society, mainly due to inaverted work absences. In addition an estimated 0.93 lives, representing 38.6 life years will be saved in the cohort. Conclusions. Under an assumption of neutrality relating to the potential effects of vaccination on herpes zoster virus, our model based calculations show that a national varicella vaccination programme is likely to be cost saving, not only from a societal perspective but also from the narrower health service perspective.Keywords
This publication has 74 references indexed in Scilit:
- Varicella Vaccine — The First Six YearsNew England Journal of Medicine, 2001
- The Effectiveness of the Varicella Vaccine in Clinical PracticeNew England Journal of Medicine, 2001
- Live Attenuated Varicella Vaccine for Prevention of Herpes ZosterBiologicals, 1997
- Efficacy, immunogenicity, safety, and use of live attenuated chickenpox vaccineThe Journal of Pediatrics, 1995
- Childhood vaccination against chickenpox: An analysis of benefits and costsThe Journal of Pediatrics, 1994
- Cost-effectiveness of a routine varicella vaccination program for US childrenPublished by American Medical Association (AMA) ,1994
- Social epidemiology of chickenpox in two British national cohorts.Journal of Epidemiology and Community Health, 1993
- Centers for Disease ControlThe Pediatric Infectious Disease Journal, 1984
- Live Attenuated Varicella Virus VaccineNew England Journal of Medicine, 1984
- Varicella and Herpes ZosterNew England Journal of Medicine, 1983